Miltenyi Bioindustry Webinars

1. A Novel Cell Selective Lentiviral Platform For CAR-T Engineering 5/4/2026

   Targeted lentiviral vectors enable rapid CAR‑T cell generation without extensive ex vivo manipulation. See how this approach demonstrates efficient in vitro and in vivo performance.

2. Achieving Flexibility In T Cell Manufacturing - Adaptation Of Standardized Processes 10/2/2025

   Explore how scalable CAR-T manufacturing impacts T cell biology and therapy efficacy, as well as how standardized processes can support diverse production needs while preserving critical characteristics.

3. Advances In Pediatric Transplant: T-Cell Depleted Haploidentical Experience 9/11/2025

   Explore how T cell–depleted haplo-HSCT is expanding donor options for pediatric patients, with insights into clinical outcomes, immune recovery, and evolving strategies.

4. Clinical-Grade Manufacturing Of Difficult-To-Transduce Cells 3/20/2025

   Discover how Miltenyi R&D and Bioindustry experts revolutionize cellular therapy with BaEV-env LVVs as well as gain insights into preclinical evaluations and clinical-grade product development for CAR-NK cells.

5. Lessons Learned On Commercializing Lentiviral Vector As A Drug Substance: A Joint Roundtable With Adaptimmune And Miltenyi Bioindustry 10/1/2024

   Explore how your focus and strategy must evolve as you look past clinical manufacturing, process characterization and validation methods, and quality considerations when preparing for commercial production.

6. LVV Development And Manufacturing: The Beauty Of An Established Platform Process 5/17/2024

   Learn how leveraging an LVV platform can provide a fast track to GMP manufacturing, regulatory support, process characterization and validation activities to support commercialization, and more.